Halaman 5 - Kanker payudara Dokter Terbaik - TOP-171 dokter

Dr. Lucía González Cortijo is a medical oncologist with more than 20 years of experience. She has led the Medical Oncology Department at Hospital Universitario Quirónsalud Madrid since 2020. Her focus areas include breast and gynecologic cancers. She also works in precision oncology, targeted therapies, and immunotherapy.

She has been Principal Investigator in more than 20 Phase II–III clinical trials. She has also served as sub-investigator in over 50 international trials. She previously worked at Quirónsalud Madrid from 2009 to 2020. Before that, she was at MD Anderson Cancer Center Madrid from 2002 to 2009.

She holds an MD and a PhD (cum laude) from the Autonomous University of Madrid. She completed her Medical Oncology specialty training at Hospital 12 de Octubre. She also earned a Master’s in Molecular Oncology. She is a member of SEOM, ESMO, ASCO, and GEICAM. She is a university lecturer.

Dr. Tamer Mostafa Manie is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University. He is also a Consultant Breast and Oncoplastic Surgeon at Shefa Al Orman. He performs breast cancer surgery and reconstruction. His work includes CBS, mastectomy, and lumpectomy. He performs sentinel and axillary staging. He offers implant and expander reconstruction and flap options (LD, TDAP, LICAP, AICAP, TRAM, SEAP). He also performs supermicrosurgery for lymphedema. He was Breast Cancer MDT Chairman at Madinet Nasr Oncology Center from 2021 to 2023.

Qualifications: MBBCh (2003), Master’s in Surgical Oncology (2009), Doctorate in Surgical Oncology (2014). International training: Heart of England NHS Trust (2013), European Institute of Oncology, Milan (2013–2014), Nottingham Breast Institute (2023). Memberships: EGSSO and the European Society of Surgical Oncology.

Dr. Tarek M. Hashem is an Associate Professor of Surgical Oncology at the National Cancer Institute, Cairo University (since 2020). He is also a Consultant in Breast and Oncoplastic Surgery at Shefa Al Orman Comprehensive Cancer Center in Luxor (2018–present).

Focus: breast cancer management and oncoplastic surgery. Procedures include breast-conserving surgery, mastectomy, and lumpectomy. Axillary staging includes sentinel lymph node biopsy and axillary dissection. He performs reduction mammoplasty and mastopexy. Reconstruction options include implants, expanders, and flaps (LD, TDAP, LICAP, AICAP, TRAM, SEAP), as well as nipple reconstruction and lipofilling. He also performs supermicrosurgery for lymphedema.

Credentials: MBBCh (Kasr El-Aini, Cairo University). MRCS (England, 2008). Master’s in General Surgery (Kasr El-Aini, Cairo University, 2009). International Breast Surgery Fellowship per EUSOMA (Marienhospital Düsseldorf, 2011). Fellowship in Breast Surgery (Heidelberg University Hospital, 2013). Doctoral degree in Surgical Oncology (2015).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Kepala Dokter Pusat Onkologi di Assuta Medical Center – ahli terkemuka dalam pengobatan kanker payudara.

• Spesialisasi dalam onkologi dengan fokus pada kanker payudara
• Memegang peran kepemimpinan di pusat medis ternama
• Berdedikasi pada pendekatan pengobatan yang canggih dan personal

Dr. Kaduri berspesialisasi dalam penelitian kanker payudara terkait BRCA, dengan studi yang dipublikasikan tentang Oncotype Dx pada pembawa BRCA1/2. Beliau bekerja di Hadassah Medical Center.

• Melakukan penelitian terobosan di The Royal Marsden Hospital
• Mempublikasikan tentang mutasi TP53 pada pasien keturunan Arab
• Menjadi penerima penghargaan Cancer Genetics Research Foundation Award
• Menjadi anggota dari Israeli Society of Clinical Oncology

Dr. Joseba Rebollo Liceaga menghadirkan 35+ tahun keahlian onkologi terfokus pada perawatan kanker payudara di Quironsalud Torrevieja.

• Kepala departemen Onkologi di berbagai rumah sakit terkemuka di Spanyol
• Spesialisasi dalam Onkologi Medis di Clínica Universidad de Navarra
• Penelitian yang dipublikasikan tentang perawatan inovatif seperti elektro-kemoterapi
• Mengajar calon ahli onkologi sebagai mantan dokter rekanan universitas

Sebagai Kepala Pusat Perawatan Kanker Payudara di Hadassah Medical Center, Profesor Jablonski-Perec memimpin tim khusus yang berfokus sepenuhnya pada penyakit ini.

• Pengalaman lebih dari 25 tahun di bidang onkologi payudara
• Memiliki gelar Doktor Ilmu Medis
• Menjalani pelatihan di Sloan-Kettering Cancer Center yang bergengsi di New York
• Profesor Onkologi di Hebrew University
• Anggota aktif dari berbagai organisasi kanker internasional

Spesialis dalam perawatan kanker payudara dengan keahlian dari Universitas Hacettepe – salah satu pusat onkologi terkemuka di Turki.

• Spesialis onkologi medis dengan pengalaman di Rumah Sakit Onkologi Fakultas Kedokteran Universitas Hacettepe
• Anggota penuh ESMO (European Society for Medical Oncology)
• Menempuh pendidikan di Fakultas Kedokteran Universitas Ankara
• Mengobati kanker seluran pencernaan, limfoma, dan sarkoma

Spesialis dalam radioterapi untuk kanker payudara di Assuta Medical Center, dengan fokus pada perencanaan perawatan yang presisi.

• Radioterapis dengan keahlian dalam menargetkan lokasi tumor secara efektif
• Bekerja di Assuta Medical Center, yang dikenal dengan perawatan kanker tingkat lanjut
• Berdedikasi pada rencana perawatan personal untuk setiap pasien

322 publikasi peer-review – Dr. Kuemmel mengepalai Unit Payudara Multidisiplin Jerman di Kliniken Essen-Mitte.

• Direktur Klinis dari salah satu pusat kanker payudara terbaik di Jerman
• Anggota Dewan Eksekutif Arbeitsgemeinschaft Gynäkologische Onkologie
• Fakultas ESMO dengan 1.032 kuliah tamu di seluruh dunia
• Spesialisasi dalam program perawatan kanker payudara holistik

Onkolog spesialis kanker payudara di Samsung Medical Center.

• Mendiagnosis dan mengobati berbagai jenis kanker payudara
• Bekerja di salah satu pusat medis terkemuka di Korea Selatan
• Berfokus pada penyusunan rencana perawatan yang dipersonalisasi

Seung Jae Huh adalah seorang onkolog berdedikasi di Samsung Medical Center yang berspesialisasi dalam kanker payudara.

• Berspesialisasi dalam pengobatan kanker payudara
• Berpraktik di Samsung Medical Center

Onkoginekolog dengan keahlian kanker payudara di Samsung Medical Center.

• Spesialisasi dalam kanker ginekologi dan kanker payudara
• Berafiliasi dengan pusat medis terkemuka di Korea Selatan
• Fokus pada perawatan kanker yang komprehensif

Sebagai spesialis rekonstruksi payudara terkemuka di Israel, Dr. Eldor menjabat sebagai Direktur Departemen Bedah Plastik dan Rekonstruksi di Rambam Medical Center.

• Memiliki spesialisasi khusus dalam bedah rekonstruksi payudara dan wajah, termasuk bedah mikro
• Mempelajari penyebab genetik kanker payudara dan teknik reinnervasi payudara setelah perawatan
• Memiliki gelar dari American Medical School Technion dan menempuh pelatihan di AS di Baylor University
• Menjadi anggota Perkumpulan Bedah Plastik & Estetik Israel dan Asosiasi Kanker Israel

Dr. Prat berspesialisasi dalam ekspresi gen dan subtipe molekuler kanker payudara, merancang perawatan baru di SOLTI. Penelitiannya secara langsung menginformasikan perawatan pasien.

• Kepala Genomik Translasional di IDIBAPS
• Presiden SOLTI – memimpin uji klinis kanker payudara
• Lebih dari 160 publikasi dengan 13.479 sitasi
• Profesor tetap di Universitas Barcelona